Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
3.980
-0.130 (-3.16%)
At close: Jul 11, 2025, 4:00 PM
3.980
0.00 (0.00%)
After-hours: Jul 11, 2025, 8:00 PM EDT

Perspective Therapeutics Market Cap

Perspective Therapeutics has a market cap or net worth of $295.43 million as of July 11, 2025. Its market cap has decreased by -53.93% in one year.

Market Cap
295.43M
Enterprise Value
87.54M
1-Year Change
-53.93%
Ranking
Category
Stock Price
$3.98

Market Cap Chart

Since November 10, 2005, Perspective Therapeutics's market cap has increased from $49.80M to $295.43M, an increase of 493.23%. That is a compound annual growth rate of 9.47%.

History

DateMarket Cap% Change
Jul 10, 2025 305.10M 41.51%
Dec 31, 2024 215.60M 91.13%
Dec 29, 2023 112.80M 221.37%
Dec 30, 2022 35.10M -36.18%
Dec 31, 2021 55.00M 39.95%
Dec 31, 2020 39.30M -6.65%
Dec 31, 2019 42.10M 108.42%
Dec 31, 2018 20.20M -8.18%
Dec 29, 2017 22.00M -31.03%
Dec 30, 2016 31.90M -38.18%
Dec 31, 2015 51.60M -35.58%
Dec 31, 2014 80.10M 317.19%
Dec 31, 2013 19.20M -28.89%
Dec 31, 2012 27.00M 41.36%
Dec 30, 2011 19.10M -28.20%
Dec 31, 2010 26.60M 30.39%
Dec 31, 2009 20.40M 343.48%
Dec 31, 2008 4.60M -90.09%
Dec 31, 2007 46.40M -40.28%
Dec 29, 2006 77.70M 9.75%
Dec 30, 2005 70.80M 42.17%
View and export this data all the way back to 2005. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 711.91B
Johnson & Johnson 377.51B
AbbVie 339.94B
Novo Nordisk 305.41B
UnitedHealth Group 275.86B
Novartis AG 236.71B
Abbott Laboratories 229.69B
AstraZeneca 218.74B
Market Cap Rankings